PEPTID-OLIGONUKLEOTID-KONJUGATE

European patent · EP3389719 · In force

Register entry

Publication number
EP3389719
Application number
EP16876554
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 14, 2016
Published
Oct 24, 2018
Granted
Nov 17, 2021
Protection ends at the latest
Dec 13, 2036
Next annual fee due
Dec 31, 2026
IPC classes
A61K 47/50 (2017.01)
A61P 21/00 (2006.01)
A61P 31/16 (2006.01)
A61K 47/58 (2017.01)
A61K 47/64 (2017.01)
A61P 25/00 (2006.01)
A61P 31/00 (2006.01)
A61P 31/04 (2006.01)
A61P 31/06 (2006.01)
A61P 31/12 (2006.01)
A61P 43/00 (2006.01)
Priority
US 201562267723 P 15.12.2015
PCT application
PCT/US2016/066595 14.12.2016
PCT publication
WO2017/106304 22.06.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 4, 2023

    Change

    Published in Swissreg on 04.01.2023

  5. Sep 28, 2022

    Change

    Published in Swissreg on 28.09.2022

  6. Nov 17, 2021

    Granted

    Published in Swissreg on 17.11.2021

Parties

Inventor

ZHOU, Ming

Cambridge, MD 02142, US

HANSON, Gunnar, J.

Cambridge, MA 02142, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.